For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
The COVID-19 pandemic has caused significant disruption in the lives of many applicants. We recognize the unprecedented financial, academic, and personal challenges applicants may be facing during this time, including difficulty in accessing and preparing for prerequisite course work and the Medical College Admissions Test (MCAT). While Weill Cornell Medical College and the Tri-Institutional MD-PhD Program remains committed to upholding its standard of academic excellence, we recognize the historic disruption and need for flexibility during the 2020-2021 admissions cycle. Flexibility will be crucial to the successful execution of our mission to identify the most talented applicants from diverse academic and personal backgrounds.
Please click here to read about the Tri-Institutional MD-PhD Program’s current adjustments to the 2020-21 Admissions cycle.
Thank you for your patience as we work to find solutions. Please take care and stay safe!
In past years, the AMCAS verification process has taken up to eight weeks. Access to the secondary application will not be sent to the applicant until the AMCAS is verified. Applicants are encouraged to submit their application as soon as possible. Please make sure all other parts of the application (letters of recommendation) are submitted so that the admissions committee can review the application as soon as it is verified and the secondary is submitted.
With a rapidly evolving situation surrounding COVID-19, these dates are given tentatively, and we encourage applicants to check back frequently for updates and to contact the MD-PhD Program Office with any questions.
*All interviews for this application cycle will be held remotely.
Please note that the Tri-Institutional MD-PhD Program follows the Application and Acceptance Protocols established by the AAMC.
The Tri-Institutional MD-PhD Program Interview Days are listed above. If you are applying to the program, you are strongly encouraged to keep these dates open on your calendar until you hear from us regarding a final decision. As we only have three pairs interview days, rescheduling is discouraged.
MD-PhD applicants are strongly encouraged to complete their applications as early as possible. Items that typically hold an application from achieving a complete status include letters of recommendation and the medical college's secondary form. Access to the medical college's secondary form is only emailed to applicants whose applications are verified by AMCAS. It is the applicant's responsibility to make sure their file is complete.
Successful applicants will have excellent undergraduate science preparation, substantial undergraduate research experience, and a strong commitment to combining an investigative career in the biomedical sciences with clinical medicine.
Because of the increasing diversity of the United States population, there is a national need for physician-investigators who are members of underrepresented minority groups and other disadvantaged groups. The Tri-Institutional MD-PhD Program therefore encourages applications from students who are members of under-represented minority groups, from disadvantaged backgrounds or who are disabled. (We recognize that some applicants may belong to more than one of these categories.)
Successful applicants must satisfy the requirements of both the medical and the graduate components of the Program, and all matriculants must satisfy the requirements in the Medical College's Technical Standards policy.
After initial screening, selected candidates will be invited to attend one of the Program's three interview days, where they will meet selected faculty within the Program.
Successful applicants must satisfy the requirements of both the medical and the graduate components of the Program, and all matriculants must satisfy the requirements in the Medical College's Technical Standards policy. Read more about the WCM Technical Standards here.